The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.
Mario PrestiMarie Christine Wulff WestergaardArianna DraghiChristopher Aled ChamberlainAishwarya GokuldassInge Marie SvaneMarco DoniaPublished in: Cancer immunology, immunotherapy : CII (2020)
These data support clinical testing of targeted immune-regulatory strategies in the initial phase of irAE management, as a potential replacement for corticosteroids.